Home > Insider Trading > Filing (0001562180-22-001313)

Filing Details

Accession Number:: 0001562180-22-001313
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-09 19:57:15
Reporting Period:: 2022-02-07

Accepted Time:: 2022-02-09 19:57:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531048	Inari Medical Inc.	NARI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304099	William Hoffman	C/O Inari Medical, Inc. 6001 Oak Canyon Irvine CA 92618	President And Ceo	No	No	No	No

Transaction Summary

Sold:	30,000 shares	Avg. Price: $74.01	Total Value: $2,220,395.38
Number of Shares After Transactions:	538,687 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-07	30,000	$0.43	566,867	No	4	M	Direct
Common Stock	Disposition	2022-02-07	400	$71.62	568,287	No	4	S	Direct
Common Stock	Disposition	2022-02-07	6,367	$73.33	561,920	No	4	S	Direct
Common Stock	Disposition	2022-02-07	20,870	$74.18	541,050	No	4	S	Direct
Common Stock	Disposition	2022-02-07	2,363	$74.79	538,687	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2022-02-07	30,000	$0.00	30,000	$0.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
200,467		2028-05-03	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
This transaction was executed in multiple trades at prices ranging from $71.43 to $72.2050. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $72.71 to $73.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $73.7250 to $74.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $74.74 to $74.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 69 shares acquired under the Employee Stock Purchase Plan on January 31, 2022.
Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.